We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
Read MoreHide Full Article
Given low consumer confidence and weakness in the labor market, the markets are predicting rate cuts sooner than previously expected. The Federal Reserve officials, though, are still maintaining their stance that rates will remain high for a longer period. Amid such a macroeconomic backdrop, it becomes difficult to choose stocks independently and generate robust returns.
For this, one has to understand the fundamentals of a company and try to place them against the present economic background to figure out how it may fare as an investment. One way to cut short this task is to follow brokers’ recommendations.
Hence, stocks like Medpace Holdings, Inc. (MEDP - Free Report) , American Axle & Manufacturing Holdings, Inc. (AXL - Free Report) , Diebold Nixdorf, Incorporated (DBD - Free Report) , Euronet Worldwide, Inc. (EEFT - Free Report) and Omnicom Group Inc. (OMC - Free Report) are worth considering.
As brokers directly communicate with the top management, they have a deeper insight into what is happening in a particular company. They assess companies’ publicly available documents and even attend conference calls.
Brokers have more understanding of the overall sector and industry. They place company fundamentals against the current economic backdrop to determine how a particular stock will fare as an investment.
When brokers upgrade a stock, one can easily rely on their judgment. However, depending on broker upgrades is not the correct way to build your investment portfolio. Several other factors should be taken into account to ensure steady returns.
Selecting the Winning Strategy
We have a screening strategy that will help in your search for potential winners:
Broker Rating Upgrades (Four Weeks) of 1% or More: The screen selects stocks that have witnessed broker rating upgrades of 1% or more over the last four weeks.
Current Price Greater Than $5: The stocks must trade above $5.
Average 20-Day Volume Greater Than 100,000: A large trading volume guarantees that the stock is easily tradable.
Zacks Rank Equal to #1 or 2: Despite good or bad market conditions, stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) have a proven record of success. You can see the complete list of today’s Zacks #1 Rank stocks here.
VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 or 2, offer the best upside potential.
Here are five of the 20 stocks that qualified for the screening:
Headquartered in Cincinnati, OH, Medpace provides clinical research-based drug and medical device development services. MEDP offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
Medpace’s earnings estimates for 2024 have been revised 6.6% north over the past 30 days. MSDP, sporting a Zacks Rank #1, has witnessed a 16.7% upward revision in broker ratings over the past four weeks.
Headquartered in Detroit, MI, American Axle & Manufacturing is a leading supplier of driveline and drivetrain systems, modules and components for the light vehicle market. AXL manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.
American Axle & Manufacturing’s 2024 earnings estimates have been revised 26.7% upward over the past 30 days. AXL, carrying a Zacks Rank #2 at present, has witnessed a 12.5% upward revision in broker ratings over the past four weeks.
Diebold Nixdorf, based in North Canton, OH, is engaged in automating, digitizing and transforming the way people bank and shop worldwide. DBD operates through two segments - Banking and Retail.
Diebold Nixdorf’s 2024 earnings estimates have jumped 47% upward over the past 30 days. DBD, sporting a Zacks Rank #1 at present, has witnessed a 50% upward revision in broker ratings in the past four weeks.
Headquartered in Leawood, KS, Euronet is a leading electronics payments provider. EEFT offers payment and transaction processing and distribution solutions to financial institutions, retailers, consumers and service providers.
Euronet’s 2024 earnings estimates have been revised 2% upward over the past month. EEFT, carrying a Zacks Rank #2 at present, has witnessed an 11.1% upward revision in broker ratings over the past four weeks.
Omnicom, based in New York, is one of the largest advertising, marketing and corporate communications companies in the world. OMC’s agencies operate in all the major markets across the globe and provide an extensive range of services.
Omnicom’s 2024 earnings estimates have been revised 1.4% upward over the past 30 days. OMC, carrying a Zacks Rank #2 at present, has witnessed an 18.2% upward revision in broker ratings over the past four weeks.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
Given low consumer confidence and weakness in the labor market, the markets are predicting rate cuts sooner than previously expected. The Federal Reserve officials, though, are still maintaining their stance that rates will remain high for a longer period. Amid such a macroeconomic backdrop, it becomes difficult to choose stocks independently and generate robust returns.
For this, one has to understand the fundamentals of a company and try to place them against the present economic background to figure out how it may fare as an investment. One way to cut short this task is to follow brokers’ recommendations.
Hence, stocks like Medpace Holdings, Inc. (MEDP - Free Report) , American Axle & Manufacturing Holdings, Inc. (AXL - Free Report) , Diebold Nixdorf, Incorporated (DBD - Free Report) , Euronet Worldwide, Inc. (EEFT - Free Report) and Omnicom Group Inc. (OMC - Free Report) are worth considering.
As brokers directly communicate with the top management, they have a deeper insight into what is happening in a particular company. They assess companies’ publicly available documents and even attend conference calls.
Brokers have more understanding of the overall sector and industry. They place company fundamentals against the current economic backdrop to determine how a particular stock will fare as an investment.
When brokers upgrade a stock, one can easily rely on their judgment. However, depending on broker upgrades is not the correct way to build your investment portfolio. Several other factors should be taken into account to ensure steady returns.
Selecting the Winning Strategy
We have a screening strategy that will help in your search for potential winners:
Broker Rating Upgrades (Four Weeks) of 1% or More: The screen selects stocks that have witnessed broker rating upgrades of 1% or more over the last four weeks.
Current Price Greater Than $5: The stocks must trade above $5.
Average 20-Day Volume Greater Than 100,000: A large trading volume guarantees that the stock is easily tradable.
Zacks Rank Equal to #1 or 2: Despite good or bad market conditions, stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) have a proven record of success. You can see the complete list of today’s Zacks #1 Rank stocks here.
VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 or 2, offer the best upside potential.
Here are five of the 20 stocks that qualified for the screening:
Headquartered in Cincinnati, OH, Medpace provides clinical research-based drug and medical device development services. MEDP offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
Medpace’s earnings estimates for 2024 have been revised 6.6% north over the past 30 days. MSDP, sporting a Zacks Rank #1, has witnessed a 16.7% upward revision in broker ratings over the past four weeks.
Headquartered in Detroit, MI, American Axle & Manufacturing is a leading supplier of driveline and drivetrain systems, modules and components for the light vehicle market. AXL manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.
American Axle & Manufacturing’s 2024 earnings estimates have been revised 26.7% upward over the past 30 days. AXL, carrying a Zacks Rank #2 at present, has witnessed a 12.5% upward revision in broker ratings over the past four weeks.
Diebold Nixdorf, based in North Canton, OH, is engaged in automating, digitizing and transforming the way people bank and shop worldwide. DBD operates through two segments - Banking and Retail.
Diebold Nixdorf’s 2024 earnings estimates have jumped 47% upward over the past 30 days. DBD, sporting a Zacks Rank #1 at present, has witnessed a 50% upward revision in broker ratings in the past four weeks.
Headquartered in Leawood, KS, Euronet is a leading electronics payments provider. EEFT offers payment and transaction processing and distribution solutions to financial institutions, retailers, consumers and service providers.
Euronet’s 2024 earnings estimates have been revised 2% upward over the past month. EEFT, carrying a Zacks Rank #2 at present, has witnessed an 11.1% upward revision in broker ratings over the past four weeks.
Omnicom, based in New York, is one of the largest advertising, marketing and corporate communications companies in the world. OMC’s agencies operate in all the major markets across the globe and provide an extensive range of services.
Omnicom’s 2024 earnings estimates have been revised 1.4% upward over the past 30 days. OMC, carrying a Zacks Rank #2 at present, has witnessed an 18.2% upward revision in broker ratings over the past four weeks.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial of the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance